Singapore markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.85000.0000 (0.00%)
As of 12:10PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5566
Avg. Estimate-0.95-1.03-0.80.12
Low estimate-1.48-1.93-1.65-1.23
High estimate-0.34-0.530.132.72
Year ago EPS-3.410.58-5.41-0.8
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4466
Avg. Estimate101.45M76.65M849.66M929.22M
Low estimate99.8MN/A800M635M
High estimate104M152M941.8M1.26B
Year ago sales80.95MN/A983.71M849.66M
Sales growth (year/est)25.30%N/A-13.60%9.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-3.46-1.39-1.83-0.45
Actual EPS-3.410.58-1.26-1.44
Difference0.051.970.57-0.99
Surprise %1.40%141.70%31.10%-220.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.95-1.03-0.80.12
7 days ago-0.95-1.03-0.80.12
30 days ago-0.05-1.59-0.390.05
60 days ago-0.34-1.76-0.72-0.33
90 days ago-0.34-1.76-0.72-0.33
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/A233
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesNVAXIndustrySector(s)S&P 500
Current qtr.72.10%N/AN/AN/A
Next qtr.-277.60%N/AN/AN/A
Current year85.20%N/AN/AN/A
Next year115.00%N/AN/AN/A
Next 5 years (per annum)-69.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A